Uppsala, Sweden, May 31, 2011 – Biotage (STO: BIOT), a leading supplier of tools and technology for analytical and medicinal chemistry, announced a collaborative research agreement with The Laboratory of Peptide & Protein Chemistry & Biology (PeptLab) located in Florence, Italy. The renowned peptide research facility, led by Professor Anna Maria Papini, has agreed to contribute technical input towards the future development of Biotage related products as well as provide training facilities for demonstrating Biotage’s range of peptide synthesis, purification and resin products.
PeptLab is an interdepartmental structure of the University of Florence, located at the Polo Scientifico e Tecnologico in Sesto Fiorentino, founded in 2004 by Professor Paolo Rovero (Dept. of Pharmaceutical Sciences), Professor Anna Maria Papini and Dr. Mario Chelli (Dept. of Organic Chemistry ‘Ugo Schiff’), and Professor Francesco Lolli (Dept. of Neurological Sciences).
Since 2009, the PeptLab proof-of-concept incorporated the French Laboratory, SOSCO of the University of Cergy-Pontoise (where expertise in glycol-chemistry and fluorine chemistry are present). This was made possible thanks to a Chaire d\'Excellence provided to Prof. Papini and financial support from the French Agence Nationale de la Recherche, with the idea of organizing a European Innovation Network to introduce a “Quality Approach” as an innovative strategy for R&D activities in Academic Laboratories and SMEs, providing Good Practice Guidance initially in the field of peptide-based diagnostics.
“Biotage is very fortunate to have the opportunity to collaborate with Professor Papini and the PeptLab team.” said Torben Jörgensen, President and CEO of Biotage AB, “We are all very excited by the opportunity to work with this prestigious group and are looking forward to our collaboration across a wide range of activities.”
Prof. Papini remarked that “It is evident that the cooperation with Biotage fits perfectly with our goals both within PeptLab itself and the wider framework of the European Innovation Network. It is for this reason that we decided to invest in the Biotage Syro II and Syro Wave® parallel peptide synthesizers for our SOSCO Laboratory in Cergy-Pontoise. These innovative tools allow us to significantly increase our peptide production as well as provide access to more challenging peptides via the microwave heating capability of the Syro Wave®. Such state-of-the-art equipment, along with a strong commitment not only in research, but also to education and technology transfer are characteristics of the PeptLab life and the collaboration with Biotage”.
For more information on the Biotage Peptide Purification and Synthesis products, please email email@example.com or visit www.biotage.com/peptides
For more information regarding the Laboratory of Peptide and Protein Chemistry and Biology (PeptLab), visit www.unifi.it/peptlab.
For further press information at Biotage please contact: Rob Thompson, Director of Marketing Communications, 10430 Harris Oaks Blvd., Suite C, Charlotte, NC USA 28269 Tel: +1 704 654 4847 Fax: +1 704 654 4917 Email: firstname.lastname@example.org
Biotage offers solutions, knowledge and experience in the areas of analytical chemistry and medicinal chemistry. The customers include the world’s largest pharmaceutical and biotech companies, and leading academic institutes. The company is headquartered in Uppsala with subsidiaries in the US, UK and Japan. Biotage has 272 employees and sales of 428.9 MSEK in 2010. Biotage is listed on the NASDAQ OMX Nordic Stockholm stock exchange. Website:www.biotage.com
Two New Methods for Extraction of a Steroid Hormone Panel from Human Urine
New Method for Extraction of a Steroid Panel from Horse Hair
New Method for Analysis of Environmental Pesticides in Water
"I Was Surprised that Everything Worked So Well". A Researcher on Moving to Automated Sample Prep
Notice of Discontinuation of Biotage® SNAP Flash Columns